BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 35020717)

  • 1. The global epidemiology of chikungunya from 1999 to 2020: A systematic literature review to inform the development and introduction of vaccines.
    Bettis AA; L'Azou Jackson M; Yoon IK; Breugelmans JG; Goios A; Gubler DJ; Powers AM
    PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010069. PubMed ID: 35020717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A patent perspective on chikungunya.
    Dapurkar D; Telang M
    Acta Trop; 2019 Nov; 199():105131. PubMed ID: 31401192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chikungunya, a paradigm of neglected tropical disease that emerged to be a new health global risk.
    Rougeron V; Sam IC; Caron M; Nkoghe D; Leroy E; Roques P
    J Clin Virol; 2015 Mar; 64():144-52. PubMed ID: 25453326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development.
    de Lima Cavalcanti TYV; Pereira MR; de Paula SO; Franca RFO
    Viruses; 2022 May; 14(5):. PubMed ID: 35632709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of Chikungunya in the Americas.
    Yactayo S; Staples JE; Millot V; Cibrelus L; Ramon-Pardo P
    J Infect Dis; 2016 Dec; 214(suppl 5):S441-S445. PubMed ID: 27920170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The research progress of Chikungunya fever.
    Cai L; Hu X; Liu S; Wang L; Lu H; Tu H; Huang X; Tong Y
    Front Public Health; 2022; 10():1095549. PubMed ID: 36699921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya Virus.
    DeZure AD; Berkowitz NM; Graham BS; Ledgerwood JE
    J Infect Dis; 2016 Dec; 214(suppl 5):S497-S499. PubMed ID: 27920180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updates on chikungunya epidemiology, clinical disease, and diagnostics.
    Sam IC; Kümmerer BM; Chan YF; Roques P; Drosten C; AbuBakar S
    Vector Borne Zoonotic Dis; 2015 Apr; 15(4):223-30. PubMed ID: 25897809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chikungunya as a paradigm for emerging viral diseases: Evaluating disease impact and hurdles to vaccine development.
    Rezza G; Weaver SC
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006919. PubMed ID: 30653504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory considerations in development of vaccines to prevent disease caused by Chikungunya virus.
    Yang S; Fink D; Hulse A; Pratt RD
    Vaccine; 2017 Sep; 35(37):4851-4858. PubMed ID: 28760614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High level of vector competence of Aedes aegypti and Aedes albopictus from ten American countries as a crucial factor in the spread of Chikungunya virus.
    Vega-Rúa A; Zouache K; Girod R; Failloux AB; Lourenço-de-Oliveira R
    J Virol; 2014 Jun; 88(11):6294-306. PubMed ID: 24672026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 51 years in of Chikungunya clinical vaccine development: A historical perspective.
    Reyes-Sandoval A
    Hum Vaccin Immunother; 2019; 15(10):2351-2358. PubMed ID: 30735447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress on chikungunya virus research.
    An W; Ge N; Cao Y; Sun J; Jin X
    Virol Sin; 2017 Dec; 32(6):441-453. PubMed ID: 29188427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Vaccines for Chikungunya Fever.
    Erasmus JH; Rossi SL; Weaver SC
    J Infect Dis; 2016 Dec; 214(suppl 5):S488-S496. PubMed ID: 27920179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chikungunya Virus Vaccine Candidates with Decreased Mutational Robustness Are Attenuated
    Carrau L; Rezelj VV; Noval MG; Levi LI; Megrian D; Blanc H; Weger-Lucarelli J; Moratorio G; Stapleford KA; Vignuzzi M
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31270226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chikungunya: Its History in Africa and Asia and Its Spread to New Regions in 2013-2014.
    Zeller H; Van Bortel W; Sudre B
    J Infect Dis; 2016 Dec; 214(suppl 5):S436-S440. PubMed ID: 27920169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chikungunya Beyond the Tropics: Where and When Do We Expect Disease Transmission in Europe?
    Tjaden NB; Cheng Y; Beierkuhnlein C; Thomas SM
    Viruses; 2021 May; 13(6):. PubMed ID: 34072346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chikungunya fever in Africa: a systematic review.
    Russo G; Subissi L; Rezza G
    Pathog Glob Health; 2020 May; 114(3):136-144. PubMed ID: 32308158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent development in the strategies projected for chikungunya vaccine in humans.
    Goyal M; Chauhan A; Goyal V; Jaiswal N; Singh S; Singh M
    Drug Des Devel Ther; 2018; 12():4195-4206. PubMed ID: 30573950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen.
    Burt FJ; Chen W; Miner JJ; Lenschow DJ; Merits A; Schnettler E; Kohl A; Rudd PA; Taylor A; Herrero LJ; Zaid A; Ng LFP; Mahalingam S
    Lancet Infect Dis; 2017 Apr; 17(4):e107-e117. PubMed ID: 28159534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.